May 28th - May 29th, Hotel Munkebjerg, Vejle, Denmark
REGISTRATION IS NOW OPEN!
The Danish Conference on Biotechnology and Molecular Biology is back for 2019 with it's 14th edition
The field of therapeutic proteins has been expanding for several years and is more relevant than ever. The huge clinical success of many of these proteins and the large potential of the treatments being developed, requires scientists of diverse backgrounds with many different competences to solve some of the most pressing questions. The potential is reflected in a therapeutic protein market that accounts for more than $100 billion and is estimated to triple in the next 10 years.
The 14th Danish Conference on Biotechnology and Biomedicine will focus on some of the most interesting topics within Therapeutic Proteins and highlight some of the cutting edge research.
The conference will include sessions on:
o Therapeutic antibodies
o Peptides and Hormones
o Cell Line Engineering and Protein Production Systems
o Protein Engineering and Computational Protein Design
o Post-Translational and Chemical Modifications of Therapeutic Proteins
As well as a session on innovation and entrepreneurship.
Furthermore, there will be poster sessions where students and young researchers can display their research and winners of a poster competition will be able to present their research on the main stage.
o Jan van de Winkel, CEO of Genmab
o Mathias Uhlén, Professor at the Royal Institute of Technology (KTH) Stockholm
o Mads Hald Andersen, Vice-Director at the Center for Cancer Immune Therapy (CCIT)
o Christoph Herwig, Professor at the Technical University of Vienna
o Dario Neri, Professor at ETH Zurich
o Jens Nielsen, Head of the BioInnovation Institute
o Andreas Laustsen, Associate Professor at the Technical University of Denmark
o Claus Kristensen, CEO of GlycoDisplay
o Franca Fraternali, Professor at Kings College London
o Søren Madsen, Head of Department, Bacterial Expression at Bioneer
o Ana Rute Neves, Senior Department Manager at Chr. Hansen
o Søren Østergaard, Principle Scientist at Novo Nordisk
o Pernille Winding Gojkovic, CEO of HØIBERG
The conference is organized by the Danish Biotechnological Society and IDA Biotechnology.
See the program for the conference here
Copyright © All Rights Reserved